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Clinical and Electrophysiological Characterizat ion of Myokymia
and Neuromyotonia in Jack Russel l Terriers
A.E. Vanhaesebrouck, I. Van Soens, L. Poncelet, L. Duchateau, S. Bhatti, I. Polis,
S. Diels, and L. Van Ham
Background: Generalized myokymia and neuromyotonia (M/NM) in Jack Russell Terriers (JRTs) is related to peripheral
nerve hyperexcitability syndrome in humans, a symptom complex resulting from diverse etiologies.
Objective: Clinical and electrodiagnostic evaluation is used to narrow the list of possible etiological diagnoses in JRTs with
M/NM.
Animals: Nine healthy JRTs and 8 affected JRTs.
Methods: A prospective study was conducted comparing clinical and electrophysiological characteristics in 8 JRTs affected
by M/NM with 9 healthy JRT controls.
Results: All affected dogs except 1 had clinical signs typical of hereditary ataxia (HA). In 6 dogs, neuromyotonic discharges
were recorded during electromyogram. Motor nerve conduction studies showed an axonal neuropathy in only 1 affected dog.
Compared with controls, brainstem auditory-evoked potentials (BAEP) showed prolonged latencies (Po .05) accompanied by
the disappearance of wave components in 3 dogs. Onset latencies of tibial sensory-evoked potentials (SEP) recorded at the
lumbar intervertebral level were delayed in the affected group (Po .001). The BAEP and SEP results of the only neuromyo-
tonic dog without ataxia were normal.
Conclusions and Clinical Importance: The BAEP and spinal SEP abnormalities observed in JRTs with M/NM were asso-
ciated with the presence of HA. Therefore, these electrophysiological ﬁndings presumably arise from the neurodegenerative
changes characterizing HA and do not directly elucidate the pathogenesis of M/NM. An underlying neuronal ion channel
dysfunction is thought to be the cause of M/NM in JRTs.
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The clinical term myokymia describes continuous ver-miform movements of the overlying skin or mucous
membrane and the term neuromyotonia describes sus-
tained generalized muscle stiffness. Both conditions are
characterized by a similar electromyographic (EMG) pat-
tern of repetitive bursts of single motor unit action
potentials.1 Neuromyotonic discharges mainly differ from
myokymic discharges by their higher intraburst frequen-
cies.2 Because these electrophysiological phenomena do
not always correlate with their analogous clinical terms,
myokymic and neuromyotonic discharges need to be dis-
tinguished from clinical myokymia and neuromyotonia.2
These terms have been used inconsistently in the literature.
Generalized myokymia and neuromyotonia (M/NM)
appear to be emerging clinical phenomena in the Jack
Russell Terrier (JRT) breed. In veterinary literature, M/
NM has been described in 7 dogs and 1 cat.3–5 These
animals typically showed widespread vermicular subcu-
taneous muscular contractions and episodes of sustained
generalized muscle stiffness triggered by effort or stress.
During EMG, repetitive bursts of motor unit discharges
were recorded. Three of the 7 described dogs were JRTs,
all having an early onset of clinical signs.4 In these JRTs,
M/NM was typically seen in association with hereditary
ataxia (HA).4 A deﬁnitive cause could not be identiﬁed in
any of these dogs. In addition, focal myokymia has been
described in 2 dogs.6,7
In humans, M/NM belongs to the peripheral nerve
hyperexcitability (PNH) syndrome.8 This syndrome con-
sists of all clinical forms of involuntary muscular
contractions resulting from an excessive excitability of
the peripheral nerve, including fasciculations, cramps,
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myokymia, and neuromyotonia. Because several causes
can be responsible for PNH in humans, the aim of our
study was to describe in detail the clinical and electro-
physiological features in JRTs with M/NM in order to
narrow the wide range of possible etiologies.
In humans, the generalized PNH syndrome usually is
due to a potassium channelopathy of the peripheral
nerve, either inherited in children9 or immune-mediated
in adults.10 In these cases, additional electrodiagnostic
evaluation is usually unremarkable, except for the EMG
discharges.10,11 Uncommonly, it may be a manifestation
of an underlying peripheral neuropathy, in which the
nerve conduction study reﬂects the underlying disor-
der.8,12 Recently, its association with some forms of HA
in humans has been recognized.13–15 In humans with HA,
brainstem auditory-evoked potential (BAEP) and sen-
sory-evoked potential (SEP) abnormalities are common
features.16
In this prospective study, the clinical and electrophys-
iological data were compared between 8 JRTs with M/
NM and 9 healthy JRTs in order to direct future genetic,
histopathological, and immunopathological research.
This research should clarify the deﬁnitive etiological
pathogenesis of M/NM in JRTs.
Material and Methods
Dogs
Eight JRTs, presented with signs of myokymia or neuromyoto-
nia (deﬁned as vermicular muscle twitching or muscle stiffness,
respectively) affecting at least 2 different muscular regions, were
prospectively investigated between 2006 and 2009 at the Neurology
Department for Small Animals of Ghent University. The age of the
dogs at presentation was 10  6.82 months (mean  standard devi-
ation [SD]; range, 3.5–25 months). No patient had a history of
exposure to toxins or recent medication. Nine clinically healthy and
neurologically normal JRTs served as controls. The age of the con-
trols was 6.3  3.1 years (range, 1.5–10 years).
The results of clinical, laboratory, and electrophysiological data
were compared between the study and the control group, with the
exception of cerebrospinal ﬂuid (CSF) analysis, which was not per-
formed in controls. The study was conducted in accordance with the
guidelines of the local Ethics Committee (reference EC 2008/025).
Owners of all the dogs enrolled gave informed consent.
History and Clinical Examination
Medical histories, using a standard questionnaire (including fam-
ily history), were obtained by personal communication with the
owners. Each dog was fully evaluated clinically by the same inves-
tigator (A.E.V.). A CBC and serum biochemistry proﬁle was
performed in all dogs, including creatine kinase (CK), total calcium,
magnesium, thyroxine, and thyroid-stimulating hormone concen-
trations. Serum was tested for acetylcholine receptor antibodies by
immunoprecipitation radioimmunoassay.a,17 Routine urine analysis
was performed. Plasma lactate, amino acid, and carnitine concen-
trations were measured by enzymatic spectrophotometry,18 ion
exchange chromatography19 and tandem mass spectrometry,20 re-
spectively. Urinary organic acids were quantiﬁed by gas
chromatography mass spectrometry.21 The white blood cell (WBC)
count and total protein concentration in CSF were analyzed in the
study group only. Cytology of CSF sediment was only performed in
dogs with increased CSFWBC count, deﬁned as48WBC/mL.
Electrophysiological Studies
A commercial electrophysiologic unitb was used for all electrodi-
agnostic recordings. All electrophysiological recordings were
performed with the dogs under general anesthesia, except for BAEP
recording, which was performed under sedation. Dogs were pre-
medicated with dexmedetomidinc (20mg/kg IV). Anesthesia was
induced with propofold (1.5–2mg/kg to effect, IV) and maintained
with isoﬂuranee (1–1.5%) in oxygen. Capnography and pulse ox-
imetry were monitored. The body temperature was measured at
regular intervals during each recording session. Infrared lamps or a
warm waterbed was used to prevent hypothermia. In 1 dog, because
of muscle artifacts during SEP recording, curarization was induced
using atracurium (0.25mg/kg IV). Train-of-four stimulation of the
ulnar nerve was used to monitor the level of neuromuscular block-
ade. The dog was ventilated by intermittent positive pressure.
Bilateral BAEP recordings were obtained in response to click
stimuli delivered through headphones at a 90 dB normal hearing
level and at a stimulus rate of 10Hz.22 Responses to 256 stimuli were
averaged and 2 subsequent recordings were performed at each side.
Waves I–V were analyzed. Peak latencies, as well as interpeak
latencies between peaks I–III, III–V, and I–V, were determined.
EMG, motor nerve conduction (MNC), repetitive nerve stimula-
tion (RNS), and SEP were recorded unilaterally. Standard needle
EMG recordings were made from 13 appendicular muscles of 1 side
of the body (Fig 1). All other muscles of this body site, in which
clinical myokymia was apparent, were also tested. Myokymic and
neuromyotonic discharges were deﬁned as spontaneous bursts of
doublet, triplet, or multiplet motor unit discharges of a single or
partial motor unit and distinguished by their intraburst frequency
(5–150 and 150–300Hz, respectively).1,2
MNC velocities and response amplitudes recorded from the cra-
nial tibial muscles were measured after stimulation of the peroneal
nerve.23 Measurements of decremental responses in amplitude of
compound muscle action potentials (CMAP) from the cranial tibial
muscle to RNS at a slow stimulus rate of 3Hz were performed in all
patients and controls.24
SEPs were obtained after tibial nerve stimulation at the hock.25
Recording electrodes were placed between the spinous processes of
the lumbar vertebrae L4–L5 and L6–L7 as well as on the sciatic
nerve at the level of the greater trochanter. Stimuli of 0.2ms dura-
tion and 3Hz repetition rate were used. The evoked potentials
were ampliﬁed and bandpass ﬁltered between 20 and 2 kHz. Two
hundred ﬁfty responses were averaged and 2 averages were super-
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Fig 1. Electromyographic distribution of neuromyotonic dis-
charges in Jack Russell Terriers with generalized myokymia and
neuromyotonia (n5 8). Recordings were performed on 1 side of the
body. A broken line separates fore- and hind limb muscles. The
white and black bars represent proximal and distal limb muscles,
respectively, showing that proximal and distal muscles are affected
equally.
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imposed. The onset latencies and peak-to-peak amplitudes of each
potential were measured. Time from onset to the cord dorsum po-
tential (CDP) peak of L4–L5 (onset-to-peak latency) was also
measured.26 Figure 2 shows the cardinal components used for SEP
analysis.
Statistical Analysis
The Wilcoxon rank sum test was used to compare the 2 groups
with respect to BAEP and MNC variables. The SEP onset latency
and amplitude variables were compared between the 2 groups using
a mixed model with dog as random effect and group, recording
electrode position and their interaction as ﬁxed effects. The SEP
results were adjusted for height. Statistical analysis was performed
by commercially available software.f Results are expressed as mean
values with the SD, unless stated otherwise.
Results
Epidemiology
Male dogs (n5 6) outnumbered female dogs (n5 2) in
the affected group (3 : 1). In dogs with neuromyotonic
signs (n 5 7), the mean age of onset was 5.5 months
(range, 3–9 months). All owners reported myokymic
signs to be present simultaneously or sometime before
(up to several months) the onset of neuromyotonic signs.
In dogs with ataxia (n 5 7), subtle signs of ataxia ap-
peared to be present at the time they were obtained by
their current owner (ie, at the age of 2 months, except for
1 dog, which was purchased at the age of 4.5 months). In
all of these dogs, ataxia preceded myokymic and neu-
romyotonic signs. Three owners reported that the ataxic
gait in their dog became clearly obvious after the 1st neu-
romyotonic attack. One dog showed a cluster of general-
ized tonic-clonic seizures at the age of 11 months.
History
All affected dogs had a history of muscle twitching
with or without muscle stiffness, called myokymia (n 5
8) and neuromyotonia (n5 7), respectively. Exercise, ex-
citement, or other stress triggered or exacerbated all
motor features in the majority of patients (n5 7). Neuro-
myotonic attacks tended to occur more frequently during
hot weather. Sensory manifestations, in the form of facial
rubbing, were observed in 5 dogs. Hyperthermia (range,
39.4–421C) with tachypnea and tachycardia were noted
in 6 dogs during neuromyotonic attack. Vomiting or di-
arrhea was sporadically reported several hours after signs
of skeletal muscle hyperactivity in 4 dogs. One dog de-
veloped urinary incontinence during the course of the
disease.
The clinical course evolved from episodic to nearly
continuous myokymia in 4 of the 8 dogs. The frequency
of neuromyotonic attacks varied from occasionally to
weekly. The mean duration of the attacks was between 1
and 3 hours (range, 10 minutes to 12 hours). Two dogs
seemed to be in pain and vocalized during the neuromyo-
tonic episodes.
All affected dogs had limb myokymia (n5 8). Six dogs
had additional overactivity of trunk muscles (n 5 2) (in-
cluding thorax, abdomen, spine, neck), head muscles (n
5 2) (including tongue, muzzle, eyelid), or both (n 5 4).
Muscle overactivity affected lower limb (n 5 8) more
than upper limb (n 5 7) muscles. Although 2 owners re-
ported more prominent involvement of 1 or 2 legs on the
same or the opposite side, the distribution of muscular
contractions appeared symmetrical and bilateral during
all consultations and reevaluations.
Clinical Examination
Clinical myokymia was present in 7 of 8 patients at the
time of consultation. Additionally, 2 dogs developed neu-
romyotonia during clinical examination. Apart from
one, all affected dogs demonstrated clinical signs typical
of HA, including uncoordinated and hypermetric gait.
Neurologic examination identiﬁed delayed conscious
proprioception in the left hind limb in 1 dog and a bilat-
eral poor menace response in another dog.
Laboratory Investigations
Serum CK activity was mildly to moderately increased
in 6 affected dogs (range, 244–1,093 IU/L; control
Fig 2. Tibial SEP recorded at the intervertebral level of L6–L7 (A) and L4–L5 (B) (5mV/vertical division, 5ms/horizontal division). The
onset latency was measured from the stimulus to the initial positive (downward) deﬂection (peak 1). Onset-to-peak latency difference of the
CDP was also analyzed (time from peak 1 to peak 2). Sensory-evoked potentials amplitudes were calculated from peak-to-peak (vertical
distance between peak 1 and peak 2).
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dogs, 186  51 IU/L). Alanine transaminase (ALT) and
aspartate transaminase (AST) were mildly to severely
increased in 3 and 4 affected dogs, respectively (range,
55–555 and 44–4,176 IU/L; control dogs, 38.6  11.41
and 32.3  11.29 IU/L, respectively). Muscle enzymes
were more severely increased in dogs with recent ne-
uromyotonic attacks. All patients and controls had
normal serum total calcium and magnesium concentra-
tions. All dogs were euthyroid based on clinical and
biochemical evaluation. Antiacetylcholine receptor anti-
body titers were normal in all dogs. Amino and organic
acid screening was similar among groups. No CSF ab-
normalities were found in the affected group. The CSF
WBC count varied between 0 and 4WBC/mL.
Electrophysiological Investigations
The median peak and interpeak BAEP latencies are
presented in Table 1. Peak latencies of all BAEP waves
and interpeak latency intervals I–V were statistically
longer in the affected group than in the control dogs
(Po .05). In 3 affected dogs, there was unilateral (n5 1)
or bilateral (n 5 2) loss of waves III/IV and V. Latency
results in the neuromyotonic dog without ataxia were
normal.
The most common EMG abnormalities were doublet,
triplet, and multiplet discharges of motor unit action po-
tentials, with amplitudes varying between 100mV and
1mV. The auditory ﬁring pattern was recognized as
semirhythmic, meaning that bursts recurred in orderly,
but not precise, intervals.27 The interburst frequency
ranged from 10 to 40Hz (Fig 3). These repetitive bursts
exhibited high intraburst frequencies (155–260Hz), char-
acteristic of neuromyotonic discharges. Neuromyotonic
discharges were not inﬂuenced by general anesthesia, but
neuromuscular blockade with atracurium performed in
1 dog abolished neuromyotonic discharges.
These neuromyotonic discharges, observed in 6 af-
fected dogs, were usually associated with clinically
visible myokymia. Only 2 of these dogs had signs of clin-
ical neuromyotonia at the time of anesthetic induc-
tion. In these 2 dogs, bursts had a higher number of mo-
tor unit discharges (410), a longer duration (410ms),
and waning amplitudes, compared with the other af-
fected dogs, apart from 1 dog, which only showed
myokymia but had similar severe EMG ﬁndings. Occa-
sional ﬁbrillation potentials, positive sharp waves, or
both were observed in distal forelimb muscles of 2
affected dogs. In 2 dogs, no neuromyotonic discharges
could be recorded. In the 1st dog, clinical myokymia was
not observed during consultation, but was observed at a
recheck examination performed 4 months after the initial
diagnostic tests. In the 2nd dog, myokymia was present
at the time of consultation, but had disappeared at the
time of EMG examination.
Proximal and distal appendicular muscles were af-
fected equally (Fig 1). In 4 patients, discharges addition-
ally were recorded in lingual (n 5 2), abdominal (n 5 3),
and lumbar (n 5 2) muscles. The highest number of
spikes per burst was noted in the tibialis cranialis, exten-
sor carpi radialis, ﬂexor digitorum profundus, and biceps
brachii muscles.
No statistically signiﬁcant differences were found in
MNC velocity (P 5 .20) and amplitudes (P 5 .53) be-
tween cases and controls. However, 1 affected dog
demonstrated markedly low proximal and distal CMAP
amplitudes (7.6 and 5.9mV; control values, 28.25  8.88
and 26.7 9.07mV, respectively). There was no evidence
of clinical relevant decremental response in CMAP am-
plitude during RNS in any of the dogs. An incrementing
response was found in the 4 youngest affected dogs (o7
months), ranging from 7 to 25%.
The results of SEP for cases and controls are shown in
Table 2. Both mean onset and peak latencies of the L6–
L7 and L4–L5 SEP components were prolonged signiﬁ-
cantly in the adult patient group, consisting of all
affected dogs older than 9.5 months (n 5 3), compared
with controls (Po .001). Onset-to-peak durations of the
CDP were unchanged (P 5 .66). Interestingly, results
of the only neuromyotonic dog without ataxia were
Table 1. Results of BAEPs in JRTs (n5 8) withM/NM
compared with those in healthy JRTs (n5 9).
Dogs
Latencies (ms)
I II III/IV V I–III III–V I–V
Affected
Median 1.3 2.25 2.99 3.97 1.55 0.91 2.46
Min. 1.13 1.94 2.66 3.56 1.50 0.77 2.16
Max. 1.60 2.51 3.45 4.19 1.88 1.43 2.96
Control
Median 1.21 1.97 2.73 3.57 1.57 0.82 2.39
Min. 1.16 1.91 2.66 3.39 1.48 0.62 2.22
Max. 1.32 2.18 3.18 3.99 1.92 0.99 2.67
Min., minimum; max., maximum; BAEPs, brainstem auditory-
evoked potentials; JRTs, Jack Russell Terriers.
Data expressed as median (minimum to maximum). In 3 affected
dogs, BAEP latencies could not be recorded at 1 (n5 1) or both sites
(n5 2).
Statistically signiﬁcant difference, Po .05.
Fig 3. Neuromyotonic discharges in the form of doublets and trip-
lets, with a high intraburst frequency of approximately 200Hz
(10mV/vertical division, 10ms/horizontal division).
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normal. Results for peripheral sensory conduction for
all affected patients and control subjects were compara-
ble (P 5 .02). The amplitudes of all responses were
highly variable, although statistically similar for both
groups (P 5 .25).
Family History
In Belgium, the JRT is not recognized as an ofﬁcial
breed. Therefore, complete family data are lacking in
most of the reported cases. The female sibling of one of
the affected dogs also had signs of HA. Secondly, an 8-
month-old female dog with HA and seizures showed ma-
ternal consanguinity with one of the dogs of the present
study. In contrast, this dog had no history or signs of
myokymia or neuromyotonia. A full electrodiagnostic
evaluation of this dog identiﬁed BAEP and SEP abnor-
malities similar to those observed in the ataxic dogs with
M/NM. No electrophysiological signs of myokymia or
neuromyotonia were detected.
Discussion
This 1st prospective study of M/NM in JRTs docu-
ments the clinical and electrophysiological characteristics
of M/NM in 8 affected dogs. The diagnosis was based on
vermiform movement of the overlying skin and episodes
of generalized muscular stiffness.4,8 EMG identiﬁed
characteristic repetitive bursts of motor units1 in 6 of the
affected dogs. In the 2 remaining dogs, the diagnosis was
made based on typical history and the observation of
clinical myokymia either at the time of presentation or
during a reevaluation.
In humans, the frequent association of myokymia and
neuromyotonia is believed to represent a different mani-
festation or degree of motor PNH.28 Although motor
nerve hyperexcitability usually predominates, the PNH
syndromes also may involve sensory, autonomic, and cen-
tral nervous systems.10 In this study,460% of the affected
dogs showed intense facial rubbing, usually triggered by
stress or excitement, and frequently preceding a neuromyo-
tonic episode. This observation suggests sensory PNH.4
Other more subtle sensory signs, such as paresthesia and
numbness,10 were possibly underdiagnosed in these dogs.
Although hyperthermia, tachycardia, and tachypnea dur-
ing neuromyotonic attacks might represent autonomic
nerve hyperexcitability, these clinical signs could also be
caused by muscle overactivity.4,29 Similarly, vomiting and
diarrhea observed occasionally after motor hyperactivity
could be either a manifestation of autonomic nerve hyper-
excitability or secondary to long-lasting hyperthermia. One
dog in our series developed urinary incontinence during
the disease. Although not previously described in JRTs
with HA, this ﬁnding is probably related to the degenera-
tive spinal changes seen in this disorder rather than to
autonomic nerve hyperexcitability.30
Although some clinical signs are similar to those of
malignant hyperthermia, none of the dogs had a history
of preceding anesthesia. Only 2 humans have been re-
ported in the medical literature with concurrent M/NM
and severe hyperthermia.29,31 Whereas M/NM has been
linked to the potassium channel of the peripheral nerve,
malignant hyperthermia is generally caused by a defect in
the calcium-release channel of the skeletal muscle, the
ryanodine receptor. Since the recent recognition of the
more widespread expression of the ryanodine receptor32
and its presumed role in motor neuron diseases,33 a caus-
ative neuronal calcium channel disorder explaining both
clinical manifestations cannot be completely ruled out,
but it is considered unlikely.
Myokymia in the affected group was associated with
clinical signs of HA in all but 1 dog. Gait ataxia, if pres-
ent, always preceded the onset of myokymia and
neuromyotonia. In a previous study of HA muscle fas-
ciculations provoked by activity or excitement,
generalized seizures and respiratory distress also were
observed in several JRTs.34 We believe that the muscle
fasciculations described in this study were most probably
signs of generalized myokymia.
The ﬁnding of appendicular, facial, and truncal myo-
kymic contractions emphasizes that peripheral as well as
cranial motor nerves can be hyperexcitable. Muscle over-
activity affected pelvic muscles more than thoracic
muscles, suggesting that nerve hyperexcitability is length
dependent (ie, long nerves being the worst affected, sim-
ilar to what is observed in humans).10 Contrary to what is
observed in humans,10 distal and proximal limb muscles
seemed to be equally affected in our study (Fig 1).
Hypomagnesemia and hypocalcemia were excluded as
possible causes of PNH in this study.35,36 The most
Table 2. Tibial nerve SEP recorded over the sciatic nerve at the greater trochanter (pSEP) and from the interspinous
spaces L6–L7 and L4–L5 in JRTs with M/NM compared with those of healthy JRTs.
Dogs
pSEP L6–L7 L4–L5
Onset lat.
(ms)
Ampl.
(mV)
Onset lat.
(ms)
Ampl.
(mV)
Onset lat.
(ms)
Onset-peak lat.
(ms)
Ampl.
(mV)
Affected (n 5 7) 2.45  0.42 8.60  5.11 3.77  0.28 (n53) 2.45  5.11 4.26  0.28 (n53) 2.60  0.40 7.93  5.11
Control (n 5 9) 1.84  0.48 11.84  5.07 2.75  0.45 3.02  5.28 3.22  0.42 2.51  0.36 9.23  5.07
Lat., latency; ampl., amplitude; JRTs, Jack Russell Terriers; M/NM, generalized myokymia and neuromyotonia; SEP, sensory-evoked
potentials.
Data expressed as mean SD. Latency values are height-adjusted. In 1 affected dog SEP was not performed. For SEP latency recordings of
the affected group at the level of L6–L7 and L4–L5, only dogs older than 9.5 months (n5 3) were considered, because spinal cord maturation
could bias SEP latency results in younger dogs.
Statistically signiﬁcant difference, Po .05/35 0.0166.
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prominent biochemical ﬁnding was increased activity of
muscle enzymes (AST, ALT, CK) in all but 1 affected
dog. The increased activity of these enzyme activities is
believed to be secondary to continuous muscular con-
tractions, because their increase corresponded with
recent neuromyotonic attacks, matching their corre-
sponding half-life.4 Interestingly, in none of the dogs did
CSF analysis show an increase in total protein concen-
tration, occasionally found in humans with immune-
mediated neuromyotonia.10
BAEP results in the ataxic dogs were comparable to
those of a previous study of HA in JRTs.34 The delayed
latencies of all BAEP components indicate combined de-
generation of central as well as peripheral acoustic
pathways, as seen in humans with HA including Fried-
reich’s ataxia and several subtypes of spinocerebellar
ataxia (SCA).37,38 In 3 ataxic dogs, only the ﬁrst 2 wave
responses occurred, corresponding with the previously
described predominant degenerative lesions in the coch-
lear nuclei, trapezoid bodies, superior olivary complex,
and lateral lemnisci of the brainstem in JRTs with
HA.4,34,39 Interestingly, the single neuromyotonic dog
without gait ataxia had normal BAEP latencies.
The presence of spontaneous motor unit activity in the
form of semirhythmic bursts of doublet, triplet, or mul-
tiplet discharges of a single motor unit with an intraburst
frequency of 155–260Hz categorized all affected patients
with EMG abnormalities (6/8) in this study as having
a neuromyotonic phenotype,2 even those in which only
myokymia was observed clinically. All patients with
electrophysiological evidence of PNH had visible myo-
kymia during electrophysiological examination, of
which only 2 had apparent signs of neuromyotonia just
before anesthetic induction. The extent of the electro-
physiological abnormality (ie, duration and amplitude
of myokymic discharges) seemed to correlate with the
clinical severity of muscle hyperactivity. Recordings
were performed on 1 side of the body only, because no
obvious differences were observed clinically between
sides. In humans with M/NM, simultaneous EMG
recordings of both sides are usually similar.40
The clinical and EMG persistence of muscle activity
during general anesthesia and its disappearance after
curarization with atracurium demonstrated that the gen-
erator site for the spontaneous activity is proximal to the
neuromuscular junction.41 Atracurium binds to choliner-
gic endplate receptors, thereby competitively inhibiting
acetylcholine neurotransmitter action. In fact, local an-
esthetic peripheral nerve blocks in addition to
curarization during EMG in human patients have been
helpful in localizing the principal ectopic site of the ne-
uromyotonic discharges in the distal portion of the
peripheral nerve.41,42 Therefore, it would be valuable
to use regional anesthetics on a larger scale in JRTs with
M/NM.
Most of the affected dogs (75%) had normal motor
and sensory nerve conduction, suggesting that M/NM
can occur in the absence of peripheral nerve damage.10
Only 1 patient in this series had clear neurophysiological
evidence of damage to motor axons. This electrophysio-
logical abnormality is compatible with the predominant
axonal changes of the peripheral nerves, detected in sev-
eral JRTs affected by HA with or without M/NM.4,34,39
Repetitive nerve conduction was considered normal in
all M/NM dogs, even though RNS showed a mild incre-
mental response (o25%) in the youngest dogs. The latter
has been described previously in young adult dogs when
the cranial tibial muscle was used for CMAP recording,
presumably as a result of increased synchronicity of muscle
ﬁber discharges.24,43 More importantly, none of the dogs
had coexistent myasthenia gravis, based on the absence of
decremental response during repetitive nerve conduction
and conﬁrmed by low acetylcholine receptor antibody se-
rum titers, whereas in humans, myasthenia gravis often
occurs concurrently with autoimmune PNH.10
Although the onset latencies of SEPs recorded at L4–
L5 and L6–L7 were delayed in all ataxic dogs compared
with control dogs, onset-to-peak latencies of the CDPs
were similar. These abnormalities suggest dorsal nerve
root (cauda equina) involvement, loss of the fastest as-
cending collaterals, or both, sparing the gray matter at
the lumbar dorsal horn.26 This ﬁnding is consistent
with previous neuropathological descriptions of HA as a
bilaterally symmetrical generalized myelopathy, charac-
terized by Wallerian-type degeneration and spongy
vacuolation affecting the white matter tracts of all fun-
iculi, in particular the dorsolateral columns.4,34,39
Moreover, in dorsal spinal roots, including the cauda eq-
uina, mild to extensive ballooning of the myelin sheaths
has been observed.34,39 Interestingly, the only affected
dog without gait ataxia had normal latency results. Be-
cause in the present study the recorded SEP amplitudes
were highly variable, as reported previously, they were
considered less useful in comparing both groups.26 A re-
sponse could be recorded in each affected patient,
however, in contrast to the absence of SEP responses in
most patients with Friedreich’s ataxia, the most common
form of HA in humans.44
Because an important age difference existed between
case and control subjects, spinal cord maturation could
bias SEP results in dogs younger than 9 months. There-
fore, only 3 dogs older than 9.5 months in this study were
used to compare the onset latency and velocity results
with those of the control group. But, if conduction ve-
locity results of the youngest affected dogs in the present
study were compared with previously established SEP
values for normal young dogs,45 all results were out of
the normal range for all ataxic dogs.
The unique ﬁnding of normal BAEP and SEP results
in 1 dog with M/NM without clinical signs of HA sug-
gests that the evoked potential abnormalities in the other
affected dogs showing clinical signs of HA result from
the neurodegenerative changes due to HA. This assump-
tion is supported by the fact that BAEP abnormalities
have been reported previously in JRTs with HA34 and
the fact that BAEP and SEP abnormalities are a common
ﬁnding in humans with HA.16
The association of M/NM with HA in JRTs still re-
mains unclear. In humans, there are many causes of HA.
The electrophysiological ﬁndings in this study together
with the previous histopathological descriptions of HA
in JRTs4,34,39 resemble some subtypes of SCA.38 The
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subtype SCA3, also called the Machado-Joseph disease,
is caused by an unstable CAG-trinucleotide expansion in
the Ataxin-3 gene and has frequently been associated
with fasciculations, cramps and seldom with generalized
myokymia.13–15 An experimental study showed that a
defect in the ataxin-3 protein interferes with the potas-
sium channel function.46 Other studies demonstrated an
increase in sodium conductance.15 A similar pathomech-
anism indirectly affecting sodium or potassium channels
is a plausible explanation for M/NM in JRTs with HA.
The fact that not all M/NM dogs had HA and vice versa
could possibly be attributable to the phenotypic hetero-
geneity of the SCA.47 Interestingly, in another subtype
(SCA2), facial myokymia is dependent on the length of
trinucleotide repeats, expanding in successive genera-
tions.48 A similar mechanism could explain the absence
of M/NM in older reports of HA in JRTs.39 Alterna-
tively, as suggested before, M/NM may not have been
recognized at the time older reports34,39 were published.
The major limitations of this study are the age differ-
ence between the affected group and the control group,
and the absence of histopathologic evidence. The 1st re-
striction was minimized by only comparing SEP results
of the oldest affected dogs with the control group and
by comparing all dogs younger than 9.5 months with
previously established age-related results.45 Although
extensive histopathologic descriptions of the central and
peripheral nervous system of JRTs with HA are already
available in literature,4,34,39 the lack of histopathologic
correlation with the clinical and electrodiagnostic ﬁnd-
ings limits our understanding of this complex disorder.
Finally, the small number of cases and controls decreases
the statistical power of this study.
In conclusion, our study ruled out hypocalcemia and
hypomagnesemia as possible etiologies of M/NM in
JRTs. In addition, an underlying pure peripheral neu-
ropathy was excluded. A genetic disorder that is
associated with HA and that directly or indirectly affects
the neuronal voltage-gated potassium or sodium chan-
nels remains as a possible cause for M/NM in JRTs.
Although potassium channel antibodies were not mea-
sured (because a canine-speciﬁc test is lacking), no
clinical indications for an immune-mediated potassium
channelopathy were found.
Future evaluations should include fresh frozen muscle
and, more importantly, peripheral nerve biopsies ana-
lyzed by a neuromuscular laboratory. However,
nonspeciﬁc results are not uncommon in humans with
PNH.28 Therefore, the authors believe that, in addition,
more specialized techniques such as immunohistochem-
istry and patch clamp of neuronal ion channels will be
necessary to further elucidate the physiopathology of M/
NM in JRTs with HA. Candidate screening of several
genes for M/NM is in progress.
This study encourages a more extensive exploration of
the use of SEP in canine neurodegenerative diseases, in
particular in JRTs with HA. Meanwhile, it would be
valuable to screen every JRT with HA for M/NM on the
base of history, clinical, and EMG examination, because
currently, there is little information about the true inci-
dence of M/NM in dogs with HA.
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